Exclusive Content
Essential Clinical Trial Resources for Foreign Pharma Sponsors in China
Essential Clinical Trial Resources for Foreign Pharma Sponsors in China body { font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, san
Essential Drug Registration Resources for Foreign Pharma Companies in China
Essential Drug Registration Resources for Foreign Pharma Companies in China In 2023, the National Medical Products Administration (NMPA) processed ove
China Pharma Update: Updated Biosimilar Guidelines Released in 2026 — Key Takeaways
China Pharma Update: Updated Biosimilar Guidelines Released in 2026 — Key Takeaways On March 15, 2026, the Centre for Drug Evaluation (CDE) of the Nat
China Pharma Update: 10 Oncology Drugs Fast-Tracked by NMPA in 2026 — Key Takeaways
China Pharma Update: 10 Oncology Drugs Fast-Tracked by NMPA in 2026 — Key Takeaways The National Medical Products Administration (国家药品监督管理局, NMPA, guó
China Pharma Update: Hospital Tender Reforms Open Doors for Foreign Pharma — Key Takeaways
China Pharma Update: Hospital Tender Reforms Open Doors for Foreign Pharma — Key Takeaways As of Q1 2025, 23 provincial-level regions in China have ad
China Pharma Update: China Joins New ICH Standards — Key Takeaways
China Joins New ICH Standards: Key Takeaways for Pharma Executives As of January 2025, China's 国家药品监督管理局 (National Medical Products Administration, NM